Wednesday, February 10, 2010, 12:46PM AEST - The Australian Stockmarket closes in 3 hours and 19 minutes.
To create a watchlist or portfolio of shares, Register

Savient Pharmaceuticals, Inc. (SVNT)

 8:00AM AEST: 12.81 USD  Up 0.36 (2.89%)  
 MORE ON SVNT 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Savient Pharmaceuticals Inc (NGM:SVNT) Delayed quote dataEdit
Last Trade:12.81 USD
Trade Time: 8:00AM AEST
Change:Up 0.36 (2.89%)
Prev Close:12.45
Open:12.78
Bid:11.66 x 100
Ask:13.52 x 100
1y Target Est:16.50
Day's Range:12.46 - 12.95
52wk Range:3.45 - 16.62
Volume:743,141
Avg Vol (3m):1,041,660
Market Cap:853.48M
P/E (ttm):N/A
EPS (ttm):-2.01
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add SVNT to Portfolio   Download Data

 HEADLINES 
•Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
PR Newswire (Tue 8:35AM)
•Coverage initiated on Savient Pharma by Soleil
Briefing.com (Thu, Jan 28)
•Study: orphan drug applications doubled in 200s
AP (Thu, Jan 21)
•Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
PR Newswire (Sat, Jan 9)
•Friday Options Update: SVNT, JBLU, ROST, RVSN, MRVL, RYL, ARIA, WLP
at Seeking Alpha (Sat, Dec 19)
•Savient To Present at the 28th Annual JP Morgan Healthcare Conference
PR Newswire (Fri, Dec 11)
•SAVIENT PHARMACEUTICALS INC Financials
EDGAR Online Financials (Sat, Nov 14)
•SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
EDGAR Online (Tue, Nov 10)
•Savient Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
GlobeNewswire (Wed, Oct 28)
•SAVIENT PHARMACEUTICALS INC Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities
EDGAR Online (Fri, Oct 23)
•SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Fri, Oct 16)
More Headlines for SVNT...
 ANALYST 
EPS Est (next year) (Dec-09) :-1.83
EPS Est (in 2 years) (Dec-10) :-0.87
Avg Rec (current)*:2.1
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing, manufacturing, and marketing pharmaceutical products that target unmet medical needs.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices